Facilitation of DLA-incompatible marrow grafts by donor-specific serum transferrin?

Transplant Immunology

Volumn 4, Issue 2, 1996, Pages 113-116

  Deeg, H Joachim ^a,d   Pierpaoli, Walter ^b   Arrighi, Silvana ^c   Seidel, Kristy ^d   Graham, Theodore ^a   Huss, Ralf ^a   Yu, Cong ^a   Myerson, David ^a   Schuening, Friedrich ^a   Storb, Rainer ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Biancalana Masera Found for the A   (Italy)

^c Sclavo Inc   (Italy)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; TRANSFERRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; DOG; FACILITATION; FEMALE; HISTOCOMPATIBILITY COMPLEX; HISTOINCOMPATIBILITY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; WHOLE BODY RADIATION;

EID: 0030175174     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(96)80004-9     Document Type: Article

References (19)

1. Storb R, Deeg H.J. Failure of allogeneic canine marrow grafts after total body irradiation. Allogeneic `resistance' versus transfusion induced sensitization. Transplantation. 42:1986;571-580.
2. Storb R, Deeg H.J, Raff R, et al. Prevention of graft-versus-host disease: studies in a canine model. Sackstein R, Janssen W.E, Elfenbein G.J. Ann NY Acad Sci. 1995;149-164. Bone marrow transplantation: foundations for the 21st century.
3. Pierpaoli W, Maestroni G.J. The facilitation of enduring engraftment of allogeneic bone marrow and avoidance of secondary disease in mice. Cell Immunol. 52:1980;62-72.
4. Pierpaoli W, Kellerhals R, Buehler A, Sache E. Experimental manipulations and marrow-derived factors which affect the outcome of bone marrow transplantation across the H-2 barrier in lethally irradiated mice. J Clin Lab Immunol. 16:1985;115-124.
5. Pierpaoli W, Dall'Ara A, Yi C.X, Neri P, Santucci A, Choay J. Iron carrier proteins facilitate engraftment of allogeneic bone marrow and enduring hemopoietic chimerism in the lethally irradiated host. Cell Immunol. 134:1991;225-234.
6. Lowry O.H, Rosebrough N.J, Farr A.L, Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem. 193:1951;265-275.
7. Bates G.W, Schlabach M.R. The reaction of ferric salts with transferrin. J Biol Chem. 248:1973;3228-3232.
8. Deeg H.J, Storb R. Bone marrow transplantation in dogs. Makowka L, Cramer D.V, Podesta L.G. Handbook of animal models in transplantation research. 1994;255-285 CRC Press, Boca Raton, FL.
9. Burnett R.C, DeRose S.A, Storb R. A simple restriction fragment length polymorphism assay for MHC class II gene testing of dog families. Transplantation. 57:1994;280-282.
10. Sarmiento U.M, Storb R.F. RFLP analysis of DLA class I genes in the dog. Tissue Antigens. 34:1989;158-163.
11. Raff R.F, Storb R, Graham T, et al. What role for 15-deoxy-spergualin in enhancing engraftment of unrelated, histoincompatible canine marrow grafts and preventing graft-versus-host disease? Transplantation. 55:1993;684-688.
12. Unsgaard B. Optimal time for marrow injection in mice after total body irradiation. Acta Radiol. 56:1961;296-299.
13. Ashman R.F. B lymphocyte activation: the transferrin receptor as a prototype intermediate activation molecule. J Lab Clin Med. 116:1990;759-765.
14. Novogrodsky A, Suthanthiran M, Stenzel K.H. Ferro-mitogens: iron-cotaining compounds with lymphocyte-stimulatory properties. Cell Immunol. 133:1991;295-305.
15. Thorson J.A, Smith K.M, Gomez F, Naumann P.W, Kemp J.D. Role of iron in T cell activation: TH1 clones differ from TH2 clones in their sensitivity to inhibition of DNA synthesis caused by IgG Mabs against the transferrin receptor and the iron chelator deferoxamine. Cell Immunol. 134:1991;126-137.
16. Fowler D.H, Kurasawa K, Smith R, Eckhaus M.A, Gress R.E. Donor CD4-enriched cells of Th2 cytokine phenotype regulate graft-versus-host disease without impairing allogeneic engraftment in sublethally irradiated mice. Blood. 84:1994;3540-3549.
17. Cano E, Pizarro A, Redondo J.M, Sanchez-Madrid F, Bernabeu C, Fresno M. Induction of T cell activation by monoclonal antibodies specific for the transferrin receptor. Eur J Immunol. 20:1990;765-770.
18. Mooney M.L, Carlson P, Hastillo A, Szentpetery S, Duma R.J, Markowitz S.M. Transferrin receptors and CD4/CD8 lymphocyte ratios in rejection and infection in cardiac transplantation recipients. Transplant Proc. 22:1990;2389-2393.
19. β subsets of major histocompatibility complex class II molecules. Infect Immun. 58:1990;1461-1470.